Selected research
Industry Growth & Trends
Global Epigenome Analysis Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Epigenome Analysis Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Epigenome Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Epigenome Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Epigenome Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Epigenome Analysis Services market include Cellcentric, Syndax, Illumina, Merck, QIAGEN, F. Hoffmann-La Roche, Eisai, Abcam and Diagenode, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Epigenome Analysis Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Epigenome Analysis Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Epigenome Analysis Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Epigenome Analysis Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Epigenome Analysis Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Epigenome Analysis Services Market by Company
Cellcentric
Syndax
Illumina
Merck
QIAGEN
F. Hoffmann-La Roche
Eisai
Abcam
Diagenode
Active Motif
Zymo Research Corporation
Thermo Fisher Scientific
Enzo Life Sciences
EpiGentek Group
New England Biolabs
Epizyme
Domainex
Agilent Technologies
AsisChem
Epigenome Analysis Services Segment by Type
DNA Methylation Analysis
Analysis of DNA Interactions
Chromatin Accessibility
Conformation Assays
Epigenome Analysis Services Segment by Application
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
Epigenome Analysis Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenome Analysis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epigenome Analysis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenome Analysis Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Epigenome Analysis Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Methylation Analysis
- Analysis of DNA Interactions
- Chromatin Accessibility
- Conformation Assays
Applications
- Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Others
Companies covered
- Cellcentric
- Syndax
- Illumina
- Merck
- QIAGEN
- F. Hoffmann-La Roche
- Eisai
- Abcam
- Diagenode
- Active Motif
- Zymo Research Corporation
- Thermo Fisher Scientific
- Enzo Life Sciences
- EpiGentek Group
- New England Biolabs
- Epizyme
- Domainex
- Agilent Technologies
- AsisChem
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Epigenome Analysis Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Epigenome Analysis Services Market Size by Region (2021-2032)
- 1.4.1 Global Epigenome Analysis Services Market Size by Region (2021-2026)
- 1.4.2 Global Epigenome Analysis Services Market Size by Region (2027-2032)
- 1.5 Key Regions Epigenome Analysis Services Market Size (2021-2032)
- 1.5.1 North America Epigenome Analysis Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Epigenome Analysis Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Epigenome Analysis Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Epigenome Analysis Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Epigenome Analysis Services Market Size Growth Rate (2021-2032)
2 Epigenome Analysis Services Market by Type
- 2.1 Type Introduction
- 2.1.1 DNA Methylation Analysis
- 2.1.2 Analysis of DNA Interactions
- 2.1.3 Chromatin Accessibility
- 2.1.4 Conformation Assays
- 2.2 Global Epigenome Analysis Services Market Size by Type
- 2.2.1 Global Epigenome Analysis Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Epigenome Analysis Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Epigenome Analysis Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Epigenome Analysis Services Market Size by Regions
- 2.3.1 North America Epigenome Analysis Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Epigenome Analysis Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Epigenome Analysis Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Epigenome Analysis Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Epigenome Analysis Services Market Size Breakdown by Type (2021-2026)
3 Epigenome Analysis Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Research Institutes
- 3.1.2 Pharmaceutical Companies
- 3.1.3 Biotechnology Companies
- 3.1.4 Others
- 3.2 Global Epigenome Analysis Services Market Size by Application
- 3.2.1 Global Epigenome Analysis Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Epigenome Analysis Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Epigenome Analysis Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Epigenome Analysis Services Market Size by Regions
- 3.3.1 North America Epigenome Analysis Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Epigenome Analysis Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Epigenome Analysis Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Epigenome Analysis Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Epigenome Analysis Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Epigenome Analysis Services Industry Trends
- 4.2 Epigenome Analysis Services Industry Drivers
- 4.3 Epigenome Analysis Services Industry Opportunities and Challenges
- 4.4 Epigenome Analysis Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Epigenome Analysis Services Revenue (2021-2026)
- 5.2 Global Epigenome Analysis Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Epigenome Analysis Services Key Company Headquarters & Area Served
- 5.4 Global Epigenome Analysis Services Company, Product Type & Application
- 5.5 Global Epigenome Analysis Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Epigenome Analysis Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Epigenome Analysis Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Epigenome Analysis Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Cellcentric
- 6.1.1 Cellcentric Company Information
- 6.1.2 Cellcentric Business Overview
- 6.1.3 Cellcentric Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Cellcentric Epigenome Analysis Services Product Portfolio
- 6.1.5 Cellcentric Recent Developments
- 6.2 Syndax
- 6.2.1 Syndax Company Information
- 6.2.2 Syndax Business Overview
- 6.2.3 Syndax Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Syndax Epigenome Analysis Services Product Portfolio
- 6.2.5 Syndax Recent Developments
- 6.3 Illumina
- 6.3.1 Illumina Company Information
- 6.3.2 Illumina Business Overview
- 6.3.3 Illumina Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Illumina Epigenome Analysis Services Product Portfolio
- 6.3.5 Illumina Recent Developments
- 6.4 Merck
- 6.4.1 Merck Company Information
- 6.4.2 Merck Business Overview
- 6.4.3 Merck Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Merck Epigenome Analysis Services Product Portfolio
- 6.4.5 Merck Recent Developments
- 6.5 QIAGEN
- 6.5.1 QIAGEN Company Information
- 6.5.2 QIAGEN Business Overview
- 6.5.3 QIAGEN Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 QIAGEN Epigenome Analysis Services Product Portfolio
- 6.5.5 QIAGEN Recent Developments
- 6.6 F. Hoffmann-La Roche
- 6.6.1 F. Hoffmann-La Roche Company Information
- 6.6.2 F. Hoffmann-La Roche Business Overview
- 6.6.3 F. Hoffmann-La Roche Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 F. Hoffmann-La Roche Epigenome Analysis Services Product Portfolio
- 6.6.5 F. Hoffmann-La Roche Recent Developments
- 6.7 Eisai
- 6.7.1 Eisai Company Information
- 6.7.2 Eisai Business Overview
- 6.7.3 Eisai Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Eisai Epigenome Analysis Services Product Portfolio
- 6.7.5 Eisai Recent Developments
- 6.8 Abcam
- 6.8.1 Abcam Company Information
- 6.8.2 Abcam Business Overview
- 6.8.3 Abcam Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Abcam Epigenome Analysis Services Product Portfolio
- 6.8.5 Abcam Recent Developments
- 6.9 Diagenode
- 6.9.1 Diagenode Company Information
- 6.9.2 Diagenode Business Overview
- 6.9.3 Diagenode Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Diagenode Epigenome Analysis Services Product Portfolio
- 6.9.5 Diagenode Recent Developments
- 6.10 Active Motif
- 6.10.1 Active Motif Company Information
- 6.10.2 Active Motif Business Overview
- 6.10.3 Active Motif Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Active Motif Epigenome Analysis Services Product Portfolio
- 6.10.5 Active Motif Recent Developments
- 6.11 Zymo Research Corporation
- 6.11.1 Zymo Research Corporation Company Information
- 6.11.2 Zymo Research Corporation Business Overview
- 6.11.3 Zymo Research Corporation Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Zymo Research Corporation Epigenome Analysis Services Product Portfolio
- 6.11.5 Zymo Research Corporation Recent Developments
- 6.12 Thermo Fisher Scientific
- 6.12.1 Thermo Fisher Scientific Company Information
- 6.12.2 Thermo Fisher Scientific Business Overview
- 6.12.3 Thermo Fisher Scientific Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Thermo Fisher Scientific Epigenome Analysis Services Product Portfolio
- 6.12.5 Thermo Fisher Scientific Recent Developments
- 6.13 Enzo Life Sciences
- 6.13.1 Enzo Life Sciences Company Information
- 6.13.2 Enzo Life Sciences Business Overview
- 6.13.3 Enzo Life Sciences Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Enzo Life Sciences Epigenome Analysis Services Product Portfolio
- 6.13.5 Enzo Life Sciences Recent Developments
- 6.14 EpiGentek Group
- 6.14.1 EpiGentek Group Company Information
- 6.14.2 EpiGentek Group Business Overview
- 6.14.3 EpiGentek Group Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 EpiGentek Group Epigenome Analysis Services Product Portfolio
- 6.14.5 EpiGentek Group Recent Developments
- 6.15 New England Biolabs
- 6.15.1 New England Biolabs Company Information
- 6.15.2 New England Biolabs Business Overview
- 6.15.3 New England Biolabs Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 New England Biolabs Epigenome Analysis Services Product Portfolio
- 6.15.5 New England Biolabs Recent Developments
- 6.16 Epizyme
- 6.16.1 Epizyme Company Information
- 6.16.2 Epizyme Business Overview
- 6.16.3 Epizyme Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Epizyme Epigenome Analysis Services Product Portfolio
- 6.16.5 Epizyme Recent Developments
- 6.17 Domainex
- 6.17.1 Domainex Company Information
- 6.17.2 Domainex Business Overview
- 6.17.3 Domainex Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Domainex Epigenome Analysis Services Product Portfolio
- 6.17.5 Domainex Recent Developments
- 6.18 Agilent Technologies
- 6.18.1 Agilent Technologies Company Information
- 6.18.2 Agilent Technologies Business Overview
- 6.18.3 Agilent Technologies Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Agilent Technologies Epigenome Analysis Services Product Portfolio
- 6.18.5 Agilent Technologies Recent Developments
- 6.19 AsisChem
- 6.19.1 AsisChem Company Information
- 6.19.2 AsisChem Business Overview
- 6.19.3 AsisChem Epigenome Analysis Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 AsisChem Epigenome Analysis Services Product Portfolio
- 6.19.5 AsisChem Recent Developments
7 North America
- 7.1 North America Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Epigenome Analysis Services Market Size by Country (2021-2026)
- 7.3 North America Epigenome Analysis Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Epigenome Analysis Services Market Size by Country (2021-2026)
- 8.3 Europe Epigenome Analysis Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Epigenome Analysis Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Epigenome Analysis Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Epigenome Analysis Services Market Size by Country (2021-2026)
- 10.3 South America Epigenome Analysis Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Epigenome Analysis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Epigenome Analysis Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Epigenome Analysis Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst